chemotherapy and parp inhibitors in bc
Published 6 years ago • 203 plays • Length 8:04Download video MP4
Download video MP3
Similar videos
-
7:42
parp inhibitors in other subtypes of breast cancer
-
3:31
distinguishing between parp inhibitors in breast cancer
-
5:53
adverse-effect profiles of parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:25
dr. mizrahi on addition of parp inhibitors to chemotherapy in mutated pancreatic cancer
-
8:50
case 4: chemotherapy or parp inhibitors for brca tnbc
-
6:25
combinations with parp inhibitors for ovarian cancer
-
4:17
maintenance therapy in ovarian cancer: parp inhibitors
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
5:53
combining parp inhibitors checkpoint inhibitors in tnbc
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
0:46
parp inhibitor rechallenging in ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
4:40
solo-1 and parp inhibitors in ovarian cancer
-
1:22
dr. penson on the eligibility criteria for parp inhibitors in advanced ovarian cancer